Beximco Profit Tumble Continues Amid Hostile Macro Climate

Company Continues To Deliver Revenue Growth Alongside Profit Decline

Beximco faced another quarter of declining profits despite growing revenue, as external headwinds including increased production costs took their toll on the firm.

Person holding cellphone with logo of Beximco
A significant shareholder has opted to exit the business • Source: Shutterstock

Bangladeshi generics giant Beximco Pharmaceuticals Ltd. continued its quarterly trend of declining profits, despite net revenue growth, as macroeconomic factors dragged down its bottom line.

The firm has been warning shareholders of this anticipated decline for some time now, cautioning in November that headwinds such...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Earnings

More from Business